MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. LIPASE REAGENTS (4 X 160 TESTS); ADVIA 1800 CHEMISTRY - LIPASE (LIP)

Model Number	ADVIA 1800 CHEMISTRY - LIPASE (LIP)
Medical Device Problem Code	Imprecision (1307)
Health Effect - Clinical Code	No Known Impact Or Consequence To Patient (2692)
Date of Event	11/29/2019
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
Siemens healthcare diagnostics, inc.Has received customer complaints regarding failed calibrations and increased imprecision of quality control and patient samples when using advia chemistry lipase reagent lot 485700.Preliminary investigation has indicated that not all cartons within this reagent lot are impacted.An urgent medical device recall (umdr) chc 20-03.A.Us was sent to us customers and an urgent field safety notice (ufsn) chc 20-03.A.Ous was sent to ous customers in december 2019.The umdr and ufsn advise customers of the investigation with the advia chemistry lipase reagent lot 485700 and provide instructions to help determine if the lipase reagent cartons in their inventory are impacted.If the cartons in the customers inventory are not impacted, the customers are instructed to proceed to using the cartons according to the instructions for use.If the cartons in the customers inventory are impacted, the customers are instructed to discard the impacted cartons and can request replacement.The next reagent lot is expected to be available by february 2020.If replacement kits are not available, customers are instructed to test patient samples using an alternate methodology.
Event or Problem Description
On 1-dec-2019, the customer observed calibration failures due to reagent blank limit (rbl) failures while using lipase (lip) lot #485700 (received by the customer on 25-oct-2019) with advia 1800 chemistry system.The customer used another pack of lip lot #485700 (received by the customer on 29-nov-2019) and obtained a successful calibration.The last reagent pack was used for patient quality and control (qc) testing without issue.The customer alleged that no patient and qc results were affected by the initial calibration issue with lip lot #485700.The customer did not provide any patient and qc results.There are no known reports of patient intervention or adverse health consequences due to the calibration issue with the lip reagent.
Additional Manufacturer Narrative
The initial mdr 2432235-2020-00017 was filed on 9-jan-2020.Correction (14-jan-2020): the date of first event is (b)(6) 2019.The date of first event is not (b)(6) 2019.Corrected information from (b)(6) 2020.

• Brand Name: LIPASE REAGENTS (4 X 160 TESTS)
• Common Device Name: ADVIA 1800 CHEMISTRY - LIPASE (LIP)
• Manufacturer (Section D): SIEMENS HEALTHCARE DIAGNOSTICS INC.; 511 benedict avenue; tarrytown NY 10591
• MDR Report Key: 9572017
• Report Number: 2432235-2020-00017
• Device Sequence Number: 11533164
• Product Code: CHI
• UDI-Device Identifier: 00630414482446
• UDI-Public: 00630414482446
• Combination Product (Y/N): N
• Initial Reporter Country: FR
• PMA/510(K) Number: EXEMPT
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: foreign,health professional,u
• Initial Reporter Occupation: Other Health Care Professional
• Remedial Action: Recall
• Type of Report: Initial,Followup
• Report Date (Section B): 01/21/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 04/28/2020
• Device Model Number: ADVIA 1800 CHEMISTRY - LIPASE (LIP)
• Device Catalogue Number: 10311896
• Device Lot Number: 485700
• Was Device Available for Evaluation?: No
• Initial Date Received by Manufacturer: 12/18/2019
• Supplement Date Received by Manufacturer: 01/14/2020
• Initial Report FDA Received Date: 01/09/2020
• Supplement Report FDA Received Date: 01/21/2020
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: 2432235-01/02/2020-001-R
• Patient Sequence Number: 1